PMC:7253233 / 3381-3670 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"141","span":{"begin":3,"end":11},"obj":"Species"},{"id":"142","span":{"begin":181,"end":189},"obj":"Species"},{"id":"150","span":{"begin":17,"end":25},"obj":"Disease"},{"id":"151","span":{"begin":49,"end":65},"obj":"Disease"},{"id":"152","span":{"begin":92,"end":121},"obj":"Disease"},{"id":"153","span":{"begin":123,"end":143},"obj":"Disease"},{"id":"154","span":{"begin":149,"end":173},"obj":"Disease"},{"id":"155","span":{"begin":261,"end":280},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"Tax:9606"},{"id":"A142","pred":"tao:has_database_id","subj":"142","obj":"Tax:9606"},{"id":"A150","pred":"tao:has_database_id","subj":"150","obj":"MESH:C000657245"},{"id":"A151","pred":"tao:has_database_id","subj":"151","obj":"MESH:D034721"},{"id":"A152","pred":"tao:has_database_id","subj":"152","obj":"MESH:D002561"},{"id":"A153","pred":"tao:has_database_id","subj":"153","obj":"MESH:D001927"},{"id":"A154","pred":"tao:has_database_id","subj":"154","obj":"MESH:D004421"},{"id":"A155","pred":"tao:has_database_id","subj":"155","obj":"MESH:D009102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms. These patients also had higher levels of inflammatory markers and greater evidence of multi-organ failure. However"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T14","span":{"begin":158,"end":164},"obj":"Body_part"},{"id":"T15","span":{"begin":267,"end":272},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma32558"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma67498"}],"text":"of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms. These patients also had higher levels of inflammatory markers and greater evidence of multi-organ failure. However"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T16","span":{"begin":267,"end":272},"obj":"Body_part"}],"attributes":[{"id":"A16","pred":"uberon_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms. These patients also had higher levels of inflammatory markers and greater evidence of multi-organ failure. However"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T32","span":{"begin":17,"end":25},"obj":"Disease"},{"id":"T33","span":{"begin":49,"end":65},"obj":"Disease"},{"id":"T34","span":{"begin":98,"end":121},"obj":"Disease"},{"id":"T35","span":{"begin":129,"end":143},"obj":"Disease"},{"id":"T36","span":{"begin":261,"end":280},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0015938"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005560"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0043726"}],"text":"of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms. These patients also had higher levels of inflammatory markers and greater evidence of multi-organ failure. However"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T36","span":{"begin":149,"end":164},"obj":"http://purl.obolibrary.org/obo/UBERON_0001134"},{"id":"T37","span":{"begin":149,"end":164},"obj":"http://purl.obolibrary.org/obo/UBERON_0014892"},{"id":"T38","span":{"begin":149,"end":164},"obj":"http://www.ebi.ac.uk/efo/EFO_0000888"},{"id":"T39","span":{"begin":267,"end":272},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":"of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms. These patients also had higher levels of inflammatory markers and greater evidence of multi-organ failure. However"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":123,"end":143},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0006846"}],"text":"of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms. These patients also had higher levels of inflammatory markers and greater evidence of multi-organ failure. However"}

{"project":"LitCovid-sentences","denotations":[{"id":"T32","span":{"begin":175,"end":281},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms. These patients also had higher levels of inflammatory markers and greater evidence of multi-organ failure. However"}